CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Feb 27, 09:30
CNBX Pharmaceuticals Total Liabilities (Quarterly) : 2.584M for Nov. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Imunon, Inc. | 4.906M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0112M |
| Shareholders Equity (Quarterly) | -2.573M |
| Debt to Equity Ratio | -0.4845 |
| Current Ratio | 0.0043 |
| Net Debt Paydown Yield | 3.23% |